Modulation of oxyhemoglobin-induced protein kinase C activation by tamoxifen.
Wickman
G
G
Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2H7.
Cook
D
D
Vollrath
B
B
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D004285:Dogs; D004789:Enzyme Activation / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010108:Oxyhemoglobins / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D011493:Protein Kinase C / Q000378:metabolism*; D013629:Tamoxifen / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D018931:Antineoplastic Agents, Hormonal; D010108:Oxyhemoglobins; D013629:Tamoxifen; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate